Healthcare
Pediatrix Medical Group, Inc.(MD)
Live Price
Offline$24.16
+2.55% today
1Y Change
+78.80%
Window
Jun 25, 2025 โ Jun 15, 2026
- Market Cap
- $1.89B
- Revenue Growth
- -4.9%
- EPS Growth
- +263.0%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Pediatrix Medical Group, Inc. (MD) is a Healthcare stock with a market cap of $1.89B and listed on NYSE. The stock last traded around $24.16 and up 78.8% across the available one-year price window (Jun 25, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of -4.9%, EPS growth of +263.0%, a dividend yield of 0.0%. What stands out right now is revenue -4.9%, EPS +263.0%, free cash flow +36.9% with operating margin 11.2% and ROIC 9.0%. Valuation is more restrained than many high-expectation growth names at P/E 11.6 and price/sales 1.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-4.9% vs +7.6% peer median
Operating Margin
Below sector median
+11.2% vs +19.4% peer median
P/E
Below sector median
11.6 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -4.9% and EPS is at +263.0%, with operating margin around 11.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +7.9% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | +6.6% | +13.7% | +4.8% |
2026 Feb 19, 2026 | -5.7% | -2.5% | +2.9% | +3.1% |
2025 Nov 3, 2025 | +45.6% | +1.7% | +7.1% | +13.0% |
Benchmark Edge
MD vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MD
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MD Max Drawdown
-23.65%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MD and SPY.
Company Overview
Pediatrix Medical Group, Inc.
New York Stock Exchange
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
- Leadership
- Mark S. Ordan
- IPO Date
- Sep 20, 1995
- Employees
- 4.1k
- Street Address
- 1301 Concord Terrace
- Mailing
- Sunrise, FL, 33323
- Region
- Sunrise, FL, US
- Reporting Currency
- USD
- Investor Line
- 954 384 0175
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 11.6
- EV/EBITDA
- 8.1
- Price/Sales
- 1.0
- Price/Book
- 2.2
Growth
- Revenue
- -4.9%
- EPS
- +263.0%
- Free Cash Flow
- +36.9%
Profitability
- Gross Margin
- 25.5%
- Operating Margin
- 11.2%
- Net Margin
- 8.6%
- ROE
- 19.6%
- ROIC
- 9.0%
Balance Sheet
- Debt/Equity
- 0.76
- Current Ratio
- 1.66
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.